Date:1/28/2009

Three Months Six Months Ended Ended December 31, December 31, ---------------- ----------------- 2008 2007 2008 2007 ---- ---- ---- ---- Revenues: Net sales Biomaterial sales $13,097,048 $11,484,912 $25,768,987 $21,652,211 Endovascular sales 877,874 1,661,951 1,669,660 3,026,181 ------- --------- --------- --------- Total net sales 13,974,922 13,146,863 27,438,647 24,678,392 Royalty income 6,822,906 6,491,063 13,508,864 12,561,951 --------- --------- ---------- ---------- Total revenues 20,797,828 19,637,926 40,947,511 37,240,343 ---------- ---------- ---------- ---------- Operating costs and expenses: Cost of products sold 6,493,026 6,177,524 12,206,481 11,821,673 Research and development 4,539,173 3,959,591 8,962,922 8,891,595 Selling, general and administrative 2,119,628 5,929,374 4,405,227 13,505,966 --------- --------- --------- ---------- Total operating costs and expenses 13,151,827 16,066,489 25,574,630 34,219,234 ---------- ---------- ---------- ---------- Income from operations 7,646,001 3,571,437 15,372,881 3,021,109 Interest and other (expense) income, net (171,798) 195,918 (43,979) 422,262 -------- ------- ------- ------- Pre-tax income 7,474,203 3,767,355 15,328,902 3,443,371 Income tax expense 2,233,933 1,159,
'/>"/>

SOURCE Kensey Nash Corporation Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
Related biology technology :

1. Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results
2. Kensey Nash Corporation Announces Its Third Quarter 2008 Earnings Release Date and Teleconference
3. Kensey Nash Receives FDA 510(k) Clearance for New Safe-Cross(R) Vessel Wall Detection Technology
4. Kensey Nash to Present at the Canaccord Adams Small-Cap Orthopedics Conference
5. Kensey Nash to Participate in the Sidoti Fifth Annual Palm Beach Emerging Growth Institutional Investor Forum Conference
6. Kensey Nash to Participate in the RBC Capital Markets Healthcare Conference
7. Kensey Nash to Present at the Sidoti Sixth Annual West Coast Emerging Growth Institutional Investor Forum Conference
8. Aerolase Reports Strong Sales in 2008 for Portable Aesthetic Lasers
9. GEN Reports on Growing Reliance on Microfluidics Technology
10. Novozymes Reports Strong 2008 Results
11. International Robotic Urology Symposium Reports on Benefits of Cooling During Robotic-Assisted Prostate Surgery and Introduces InnerCools New Investigational UroCool System